A detailed history of Cladis Investment Advisory, LLC transactions in Perkinelmer Inc stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 2,000 shares of PKI stock, worth $242,000. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$242,000
Previous $242,000 -0.0%
% of portfolio
0.21%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
N/A
-830 Reduced 29.33%
2,000 $242,000
Q4 2023

Feb 13, 2024

SELL
N/A
-170 Reduced 5.67%
2,830 $342,000
Q4 2021

Oct 01, 2024

BUY
$166.66 - $201.06 $166,660 - $201,060
1,000 Added 50.0%
3,000 $603 Million
Q4 2021

May 10, 2022

BUY
$166.66 - $201.06 $499,980 - $603,180
3,000 New
3,000 $603,000

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Cladis Investment Advisory, LLC Portfolio

Follow Cladis Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.